SPI Pharma

With the emergence of CBD-based medicines, Sarath Chandar, chief scientific officer, SPI Pharma guides readers through the bioavailability challenges facing this sector of the industry. Read more


Manufacturer and supplier of controlled substance APIs, Noramco, and manufacturer and supplier of functional excipient platforms, SPI Pharma, have signed an agreement to develop and license a set of ‘value-added’ formulation packages Read more


Oral solid dosage is still the preferred method of drug delivery, however, the patient’s experience when taking medication can mean they adhere to the regimen or not. Here, Dr Brian Wilson and Dr Graeme MacLeod from SPI Pharma look at the challenges Read more

, Opinion